Video

Research Revealing Cognitive Dysfunction Causes, Treatments


 

Cognitive dysfunction is common among cancer patients. However, oncologists don't yet know enough about how to treat the condition or what causes it. Dr. Patricia Ganz and Dr. Lynne Wagner discussed the most recent studies in cognitive dysfunction at the eighth annual Chicago Supportive Oncology Conference.

Recommended Reading

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
MDedge Hematology and Oncology
ASRM: Egg Freezing No Longer 'Experimental'
MDedge Hematology and Oncology
50 Practical Medication Tips at End of Life
MDedge Hematology and Oncology
Memantine Protects Cognitive Function After Whole Brain Irradiation
MDedge Hematology and Oncology
Rivaroxaban Now Approved for DVT, PE Treatment
MDedge Hematology and Oncology
Age Ups Risk of Other Cancers in Breast Cancer Survivors
MDedge Hematology and Oncology
ASCO Update Keeps Breast Cancer Survivor Guidelines Intact
MDedge Hematology and Oncology
Doxepin Rinse Eases Mucositis Pain in Cancer Patients
MDedge Hematology and Oncology
Hypertension in cancer patients
MDedge Hematology and Oncology
Management of dermatological toxicities in patients receiving EGFR inhibitors
MDedge Hematology and Oncology